- Report
- July 2024
- 150 Pages
Global
From €5640EUR$5,950USD£4,711GBP
- Report
- August 2024
- 141 Pages
Global
From €2843EUR$2,999USD£2,375GBP
- Report
- April 2025
- 254 Pages
Global
From €4692EUR$4,950USD£3,920GBP
- Report
- April 2025
- 382 Pages
Global
From €5166EUR$5,450USD£4,316GBP
- Report
- February 2025
- 200 Pages
Global
From €4256EUR$4,490USD£3,555GBP
- Report
- March 2025
- 181 Pages
Asia Pacific
From €2701EUR$2,850USD£2,257GBP
- Report
- September 2023
- 327 Pages
Global
From €3957EUR$4,175USD£3,306GBP
- Report
- March 2024
- 150 Pages
Global
From €4597EUR$4,850USD£3,840GBP
- Report
- December 2023
- 201 Pages
Global
€4734EUR$4,995USD£3,955GBP
- Report
- July 2022
- 100 Pages
Global
From €2370EUR$2,500USD£1,980GBP
- Book
- February 2019
- 480 Pages
- Book
- January 2015
- 496 Pages
- Book
- April 2013
- 720 Pages
€2175EUR$2,458USD£1,881GBP

The Communicable Disease market within the context of Infectious Disease Testing is a rapidly growing sector of the healthcare industry. It is focused on the diagnosis and treatment of infectious diseases, such as HIV, hepatitis, and tuberculosis. The market is driven by the increasing prevalence of communicable diseases, the development of new diagnostic technologies, and the need for more accurate and timely diagnosis.
The Communicable Disease market is composed of a variety of stakeholders, including diagnostic laboratories, healthcare providers, and pharmaceutical companies. Diagnostic laboratories provide testing services for the diagnosis of communicable diseases, while healthcare providers offer treatment and management of the diseases. Pharmaceutical companies develop and market drugs to treat communicable diseases.
Some of the major players in the Communicable Disease market include Abbott Laboratories, Becton Dickinson, Cepheid, Hologic, and Roche Diagnostics. These companies offer a range of products and services, including diagnostic tests, treatments, and management solutions. Show Less Read more